TrialClinical pharmacology in drug development2020

Safety and Pharmacokinetics of High-Dose TAS-303 in Healthy Japanese Volunteers: A Single-Center, Single-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multiple-Ascending-Dose Study.

Ryuzo HanadaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.